Latest News — China Medical Tourism Association

Arion Cancer Hospital Case Breakthrough Sep 23, 2026

Gadolinium "Dual-Low" CTA with Deep Learning: An MDT Decision for Pulmonary Artery Imaging in an Iodine-Contrast-Allergic Patient | Arion — Case Breakthrough Vol. 25

A 64-year-old iodine-contrast-allergic woman with suspected pulmonary embolism underwent a gadolinium-based "dual-low" CT pulmonary angiogram — low radiation dose and low contrast volume — enhanced by deep-learning reconstruction, achieving diagnostic image quality and a confirmed PE. The MDT — radiology, cardiology, respiratory, allergy, anesthesiology — integrated protocol selection, premedication, and post-scan monitoring. Educational case review, not medical advice.

Read more Arion Cancer Hospital →

Arion Cancer Hospital Case Breakthrough Sep 23, 2026

A 34-Year-Old Man and a Giant Pelvic Tumour Across Four Hospitals: How an MDT Total Pelvic Exenteration Resolved It | Arion — Case Breakthrough Vol. 24

A 34-year-old man with a 16 cm pelvic mass (pathologically bone-extraskeletal Ewing sarcoma, ypT2N0M1) was turned away or downgraded across four hospitals before an MDT — urologic oncology, gastrointestinal oncology, anesthesiology, critical care, radiation oncology, nutrition, and rehabilitation — performed total pelvic exenteration, restoring the urinary tract with an ileal conduit and discharging him eating normally. Educational case review, not medical advice.

Read more Arion Cancer Hospital →

Arion Cancer Hospital Case Breakthrough Sep 23, 2026

A "Scarless" Rebirth Beyond Trauma: NOSES Surgery Combined with ERAS in a 65-Year-Old Rectal Cancer Patient | Arion — Case Breakthrough Vol. 23

A 65-year-old woman with rectal cancer underwent transvaginal-specimen NOSES laparoscopic resection combined with an ERAS protocol — supported by a multidisciplinary MDT in gastrointestinal oncology, colorectal surgery, anesthesiology, nutrition, and rehabilitation. Guest expert: Prof. Sergey Efetov (First Moscow State Medical University, Russia). Educational case review, not medical advice.

Read more Arion Cancer Hospital →

New Century Healthcare Pediatric Health Sep 23, 2026

How to Prevent RSV in Infants: Symptoms & Monoclonal Antibody Protection

Respiratory syncytial virus (RSV) is a leading cause of lower respiratory infection in infants. Learn what RSV is, the symptoms, and monoclonal antibody protection.

Read more New Century Healthcare →

$Refractory Chylothorax in Lymphoma: MDT-Guided Thoracic Duct Ligation Rescues a Patient on Home Nutrition | Arion — Case Breakthrough Vol. 22$

Arion Cancer Hospital Case Breakthrough Sep 22, 2026

Refractory Chylothorax in Lymphoma: MDT-Guided Thoracic Duct Ligation Rescues a Patient on Home Nutrition | Arion — Case Breakthrough Vol. 22

A 51-year-old woman with stage IVB follicular lymphoma developed massive refractory chylothorax that failed two rounds of lymphangiography and thoracic duct embolization. A multidisciplinary MDT team — thoracic surgery, hematology, gastroenterology, interventional radiology, and nutrition — performed open thoracic duct ligation, resolving the chylothorax and restoring enteral nutrition tolerance. Educational case review, not medical advice.

Read more Arion Cancer Hospital →

Foshan Chancheng Hospital Partner Hospital News Sep 21, 2026

Tenth Artificial Heart, Tenth New Life: LVAD Program Reaches New Milestone at Our Partner Hospital

The First Affiliated Hospital of Jinan University completed its tenth left ventricular assist device implantation, giving a critically ill truck driver with end-stage heart failure a new lease on life. Experts warn: chronic overwork is also a trigger of heart failure.

Read more Foshan Chancheng Hospital →

Foshan Chancheng Hospital Hospital News Sep 21, 2026

Dual-Clip DragonFly TEER for Severe Mitral Regurgitation: New Milestone in Structural Heart Intervention

Cardiology teams led by Prof. Peng Yucheng and Prof. Han Wei completed TEER with DragonFly, China's first China-EU dual-certified transcatheter mitral clip system, implanting two clips (XW0612 and SN0409) in an 82-year-old patient and bringing severe regurgitation down to trace with a mean gradient of about 5 mmHg.

Read more Foshan Chancheng Hospital →

Foshan Chancheng Hospital Hospital News Sep 21, 2026

First in Mainland China: Diamondback 360 Orbital Atherectomy System Lands in Foshan via HK-Macao Drug & Equipment Connect

Foshan Chancheng Hospital held the dual-effect orbital atherectomy symposium and completed the first clinical application in mainland China of the Diamondback 360 coronary orbital atherectomy system, with Academician Ge Junbo and leading cardiology experts joining the discussion and the procedure.

Read more Foshan Chancheng Hospital →

Foshan Chancheng Hospital Partner Hospital News Sep 21, 2026

75-Gram HeartCon II: China's Smallest Artificial Heart Brings New Hope to End-Stage Heart Failure Patient

The First Affiliated Hospital of Jinan University, together with Teda International Cardiovascular Hospital, implanted HeartCon II — a fully magnetically levitated, homegrown LVAD weighing only 75 grams — on a beating heart, off-pump, through bilateral mini-incisions.

Read more Foshan Chancheng Hospital →

Arion Cancer Hospital Case Breakthrough Sep 20, 2026

Uterine Lymphoma Mimicking Ovarian Cancer: Why Switching the Biopsy Target to the Uterus Revealed the True Culprit | Arion — Case Breakthrough Vol. 21

A 78-year-old woman with a CA125 of 538 U/mL and synchronous uterine and bilateral adnexal masses was initially thought to have metastatic ovarian cancer. Multimodal ultrasound redirected the biopsy from the adnexa to the uterus — revealing primary diffuse large B-cell lymphoma (NOS, GCB type) — and a complete metabolic response to polatuzumab vedotin plus rituximab and mini-CHP. Educational case review, not medical advice.

Read more Arion Cancer Hospital →

Arion Cancer Hospital Case Breakthrough Sep 20, 2026

Intrahepatic Cholangiocarcinoma with MSI-H Pseudoprogression: A Biopsy That Changed the Target | Arion — Case Breakthrough Vol. 20

A 57-year-old man with MSI-H/TMB-H intrahepatic cholangiocarcinoma (pT2N1M1, stage IV) showed mixed response to first- and second-line systemic therapy. A biopsy of an enlarging lesion revealed inflammatory infiltration without tumour cells — confirming immune-related pseudoprogression. Therapy was streamlined to nivolumab plus ipilimumab with reduced regorafenib, achieving stable disease. Educational case review, not medical advice.

Read more Arion Cancer Hospital →

Arion Cancer Hospital Case Breakthrough Sep 20, 2026

Chest Wall Tumor Crossing Three Ribs: Single-Stage Radical Resection and Reconstruction | Arion — Case Breakthrough Vol. 19

A 69-year-old man with a dedifferentiated leiomyosarcoma of the left chest wall grew from 5 cm to nearly 10 cm within two months, invading the latissimus dorsi and serratus anterior and crossing three ribs. An MDT-led en bloc resection removed the tumor with three ribs and reconstructed the chest wall with a titanium plate, polypropylene mesh, and a free flap in a single operation, achieving R0 resection. Educational case review, not medical advice.

Read more Arion Cancer Hospital →

Jiahui Health Hospital News Sep 18, 2026

Why Jiahui? China's Inbound Medical Tourism Story on the WTO Stage

At the WTO 2026 Public Forum in Geneva, Dr. John K. Hsiang, Chairman of Jiahui Health's Management Executive Committee, presented China's inbound medical tourism boom — 1.28 million international patient visits in 2025 — plus two real Jiahui patient cases and two policy proposals.

Read more Jiahui Health →

Jiahui Health Health Education Sep 18, 2026

Why Do Young, Fit People Have Heart Attacks? A Cardiologist Explains

Dr. Wei Meng, Director of the Jiahui Heart Center, explains why heart attacks are striking younger adults — including those who exercise — how to recognize cardiac chest pain, and the golden 120 minutes that save lives.

Read more Jiahui Health →

Foshan Chancheng Hospital Medical Milestone Sep 17, 2026

From Remission to Cure: Long-Term CAR-T Data from China Rewrites Lymphoma Treatment Standards

Five-year follow-up of Axi-cel (axicabtagene ciloleucel) shows 42.6% five-year overall survival in refractory patients, 65% complete response and 54.6% four-year survival in second-line disease, and consistent Chinese real-world evidence of 83% response — turning relapsed/refractory large B-cell lymphoma into a potentially curable disease.

Read more Foshan Chancheng Hospital →

Foshan Chancheng Hospital Medical Milestone Sep 17, 2026

Five Years of Yikaida (Axi-cel): China's First CAR-T Therapy Treats 1,500+ Lymphoma Patients

China's first approved CAR-T cell therapy marks five years: 1,500+ patients treated, its first patient cancer-free for over eight years, 200+ treatment centers in 29 provinces, and a third indication in breakthrough development.

Read more Foshan Chancheng Hospital →

HYGEIA Healthcare Case Study Sep 16, 2026

Two Cancers, Seven Years: A Dual-Primary Tumor Patient's Road to Recovery

Diagnosed with esophageal cancer in 2019 and extensive-stage small cell lung cancer with brain metastases in 2025, Mr. Yang fought two different cancers in seven years at Chongqing HYGEIA Hospital — and won both battles through radiotherapy, chemotherapy, immunotherapy, and his family's unwavering support.

Read more HYGEIA Healthcare →

Foshan Chancheng Hospital Medical Milestone Sep 15, 2026

World's First Solid-Tumor CAR-T Reaches the Clinic: Bay Area's First Patient T-Cell Collection Completed

Foshan Chancheng Hospital completed the Greater Bay Area's first T-cell collection for sattikecel (CT041), the world's first approved CAR-T for solid tumors, for a gastric cancer patient previously treated in Mongolia and South Korea.

Read more Foshan Chancheng Hospital →

Foshan Chancheng Hospital Medical Milestone Sep 15, 2026

Fosun Kairos's Dual-Target CAR-T FKC289 Cleared for Clinical Trials in Rare AL Amyloidosis

The BCMA/CD19 dual-target autologous CAR-T received implicit clinical trial approval for relapsed/refractory primary light chain amyloidosis — a rare disease with scarce treatment options.

Read more Foshan Chancheng Hospital →

Foshan Chancheng Hospital International Exchange Sep 15, 2026

China's CAR-T Goes Global: Fosun Kairos Signs Strategic MOU with Saudi Arabia's Fakeeh Care Group

The partnership will localize Fosun Kairos's CAR-T cell therapy in Saudi Arabia — covering local manufacturing, registration and commercialization under Vision 2030.

Read more Foshan Chancheng Hospital →

New Century Healthcare Pediatric Health Sep 15, 2026

Back-to-School Health: A Pediatric Check-Up Checklist

A practical back-to-school pediatric health checklist from New Century Healthcare — vaccinations, vision, sleep and habits to start the school year strong.

Read more New Century Healthcare →

GOBROAD Medical Group Hospital News Sep 11, 2026

Prof. Bian Xiaojie on the ADC Treatment Landscape in Urologic Tumors

Speaking at the 2026 Pujiang Urologic Oncology Conference in Shanghai, Prof. Bian Xiaojie explained where ADCs move from later lines to earlier lines in urothelial carcinoma, how to sequence them once an MMAE payload has been used, and how the field is expanding across genitourinary tumors.

Read more GOBROAD Medical Group →

GOBROAD Medical Group Case Study Sep 11, 2026

Crossing Mountains and Seas Toward Renewal: A Stage IV Lung Cancer Patient's Treatment Chronicle

In January 2025 a young Chinese-language teacher was diagnosed with stage IV lung adenocarcinoma with brain and multiple bone metastases. This is her own account of craniotomy, six cycles of chemotherapy, EGFR exon 19 deletion targeted therapy, Da Vinci robotic lung surgery, and MRD turning negative.

Read more GOBROAD Medical Group →

Shanghai Peace Eye Hospital Patient Education Sep 10, 2026

Diabetic Retinopathy: A 41-Year-Old's Near-Blindness Warning — Why Every Diabetic Needs Annual Retina Screening

Uncontrolled diabetes can silently damage the retina. Learn how diabetic retinopathy develops, why early screening matters, and how Shanghai HePing Eye Hospital protects vision.

Read more Shanghai Peace Eye Hospital →

HYGEIA Healthcare Case Study Sep 10, 2026

Eleven Years with an 'Old Friend': A Liver Cancer Patient's Way of Living Well

Diagnosed with liver cancer in 2015 at age 59, Mr. Lin has fought the disease for eleven years — through laparoscopic surgery, ablation, interventional therapy, and finally Gyro Knife radiotherapy at Chongqing HYGEIA Hospital, where Dr. Zhang Jinshun's team helped him turn cancer into a 'chronic disease' he lives with well.

Read more HYGEIA Healthcare →

New Century Healthcare Membership Sep 10, 2026

Panda Doctor Club Membership: Growth Benefits for Your Child

New Century Healthcare's Panda Doctor Club is welcoming new members. See the four-in-one care model, what the Panda Card includes, and growth benefits for your child.

Read more New Century Healthcare →

New Century Healthcare Women's Health Sep 10, 2026

Postnatal Recovery: What to Expect in the First Six Weeks

Gentle postnatal recovery guidance from New Century Healthcare — physical healing, emotional wellbeing and when to seek help in the first six weeks.

Read more New Century Healthcare →

GOBROAD Medical Group Clinical Trial Sep 06, 2026

AXT-1003 Phase I Trial: Recruitment Open for Advanced Malignancies

Shanghai GOBROAD Cancer Hospital is recruiting for a Phase I study of AXT-1003, a novel oral EZH2 inhibitor for relapsed/refractory lymphoma and advanced solid tumors.

Read more GOBROAD Medical Group →

HYGEIA Healthcare Case Study Sep 05, 2026

Journey of Seeking Light — A Breast Cancer Patient's Five-Year Path to Reconciliation

When a 49-year-old woman was diagnosed with breast cancer in 2021, panic gave way to resolve. Five years after surgery, chemotherapy, and radiotherapy at Chongqing HYGEIA Hospital, she is back to daily life — caring for her grandchildren, managing her household, and sharing a message of hope.

Read more HYGEIA Healthcare →

Arion Cancer Hospital Case Breakthrough Sep 04, 2026

Sigmoid Colon Cancer with Liver Metastases: A Staged, MDT-Guided Rescue

A 63-year-old man with advanced sigmoid colon cancer and multiple liver metastases underwent conversion therapy, liver-first metastasectomy, then laparoscopic primary tumor resection under a multidisciplinary MDT care plan. Educational case review, not medical advice.

Read more Arion Cancer Hospital →

GOBROAD Medical Group Hospital News Sep 04, 2026

From Drug Iteration to a Shift in Philosophy: Prof. Shen Yijun on Bladder Preservation in the ADC 2.0 Era

Speaking at the 2026 Pujiang Urologic Oncology Conference in Shanghai, Prof. Shen Yijun set out the dual upgrade reshaping bladder preservation in muscle-invasive bladder cancer: better drugs, and a new philosophy built on clinical complete response and selective treatment.

Read more GOBROAD Medical Group →

Jiahui Health Doctor Profile Sep 03, 2026

China's CAR-T Pioneer Dr. Hao Siguo Joins Jiahui as Director of Hematology

Professor Hao Siguo, a national leader in CAR-T therapy and hematopoietic stem cell transplantation, joins Jiahui International Cancer Center as Director of Hematology.

Read more Jiahui Health →

Beijing Edencare Hospital Orthopedics & Sports Medicine Sep 02, 2026

Beijing Edencare Hospital Opens Specialized Centers for Complex Limb Preservation and Finger Reconstruction

Beijing Edencare Hospital officially opens two specialized centers focused on complex limb preservation and finger reconstruction, strengthening its reconstructive microsurgery and multidisciplinary trauma care capabilities.

Read more Beijing Edencare Hospital →

Beijing Edencare Hospital Orthopedics & Sports Medicine Aug 29, 2026

Knee Pain on Stairs, After Sitting, or While Walking: What Your Joint Is Trying to Tell You

Beijing Edencare Hospital's orthopedic team explains what knee pain in different daily situations may signal, and how to protect your joints with simple, evidence-based habits.

Read more Beijing Edencare Hospital →

Shanghai Peace Eye Hospital Patient Education Aug 29, 2026

Retinal Detachment: Can It Be Cured? Key Factors That Affect Vision Recovery

Learn the warning signs, risk factors, and treatment timeline for retinal detachment from Shanghai HePing Eye Hospital's retina specialists.

Read more Shanghai Peace Eye Hospital →

Guangzhou Concord Cancer Center Hospital News Aug 28, 2026

Meet Our Medical Oncology Team: Chemotherapy, Targeted Therapy and Immunotherapy at GCCC

Meet the 5 specialists of the Department of Medical Oncology at Guangzhou Concord Cancer Center, delivering chemotherapy, targeted therapy, immunotherapy and comprehensive care for solid tumours.

Read more Guangzhou Concord Cancer Center →

Guangzhou Concord Cancer Center Hospital News Aug 28, 2026

Meet Our Radiation Oncology Team: Precision Radiotherapy and Proton Therapy at GCCC

Meet the 18 specialists of the Radiation Oncology Department at Guangzhou Concord Cancer Center, covering proton therapy, IMRT, VMAT, SBRT, Gamma Knife radiosurgery and paediatric radiotherapy.

Read more Guangzhou Concord Cancer Center →

Arion Cancer Hospital Research News Aug 28, 2026

LM101 CD19 CAR-T Receives IND Approval in China — A Science Note

A science note on LM101, a CD19-directed CAR-T cell therapy that received China IND approval in August 2026 for relapsed/refractory CD19-positive B-cell lymphoma. Explains the design concept, prior investigator-initiated trial data, and the clinical setting. Educational content, not medical advice.

Read more Arion Cancer Hospital →

Arion Cancer Hospital Case Breakthrough Aug 28, 2026

Metastatic Breast Cancer: How Molecular Profiling Revealed a PIK3CA Pathway

A 49-year-old woman with metastatic breast cancer experienced rapid progression after multiple lines of therapy. Comprehensive molecular profiling identified a PIK3CA alteration, redirecting care toward a targeted strategy. Educational case review, not medical advice.

Read more Arion Cancer Hospital →

Arion Cancer Hospital Health Education Aug 28, 2026

Adjuvant Targeted Therapy After Resection of Stage IA Lung Cancer: What the Evidence Says

A health education overview of whether patients with resected stage IA lung cancer should receive adjuvant targeted therapy. Explains the biology, recent real-world evidence, guideline limitations, and why individualized MDT decision-making matters.

Read more Arion Cancer Hospital →

Foshan Chancheng Hospital Patient Story Aug 28, 2026

“Thank You, China”: Bangladeshi Patient’s 20-Hour Skull-Base Surgery

A multidisciplinary team removed an invasive glomus jugulare tumor spanning the skull base, temporal bone and upper neck—without a blood transfusion.

Read more Foshan Chancheng Hospital →

GOBROAD Medical Group Research Aug 28, 2026

Germline Genes Guide HSCT Outcomes and Donor Selection

Frontiers in Immunology study from Beijing GOBROAD Boren Hospital: germline predisposition genes shape transplant survival and donor choice.

Read more GOBROAD Medical Group →

GOBROAD Medical Group Hospital News Aug 28, 2026

Prof. Ye Dingwei: Precision Integration in Urothelial Carcinoma

Fudan Cancer Center urologic oncology chief discusses whole-course precision care for urothelial carcinoma at the 2026 Pujiang conference.

Read more GOBROAD Medical Group →

Beijing Amcare Hospital Health Education Aug 27, 2026

From Lowering Blood Sugar to Asking Why: How Functional Medicine Helps Control Diabetes Long-Term

Beyond lowering blood sugar: how AMCARE Beijing uses functional medicine to identify the root causes of diabetes and build a sustainable control plan.

Read more Beijing Amcare Hospital →

Guangzhou Concord Cancer Center Hospital News Aug 21, 2026

From Jakarta to Surabaya: GCCC Strengthens China-Indonesia Oncology Cooperation at Medical Expo

Guangzhou Concord Cancer Center visited Jakarta and Surabaya, Indonesia from August 14-16, 2026, hosting a cancer health talk and attending the Surabaya International Health and Medical Expo to promote its proton therapy and oncology services.

Read more Guangzhou Concord Cancer Center →

Foshan Chancheng Hospital International Exchange Aug 20, 2026

Foshan Chancheng Hospital at China-Hospeq 2026: Sharing the Future of International Healthcare

The hospital presented its FIMC center, 60 Hong Kong-Macao device approvals, direct insurance billing and end-to-end international patient services at the Beijing forum.

Read more Foshan Chancheng Hospital →

Jiahui Health Patient Story Aug 19, 2026

First Foreign Patient Completes Solid Tumor CAR-T (CT041) at Jiahui and Discharges Successfully

Josh, 59, from New Zealand, is the first foreign patient to complete solid tumor CAR-T treatment with Satri-cel (CT041) at Jiahui International Cancer Center in Shanghai, China.

Read more Jiahui Health →

Beijing Edencare Hospital Endocrinology & Metabolic Health Aug 17, 2026

Weight Loss vs. Fat Loss: Why the Scale Does Not Tell the Whole Story

Beijing Edencare Hospital's endocrinology team explains why body composition matters more than body weight, and how a metabolic reset can improve blood sugar, lipids, liver health, and blood pressure.

Read more Beijing Edencare Hospital →

Jiahui Health Medical Breakthrough Aug 14, 2026

China's First DLL3/CD3 Bispecific T-Cell Engager (Tarlatamab) Now at Jiahui

Tarlatamab, a first-in-class bispecific T-cell engager for extensive-stage small cell lung cancer, is now offered at Jiahui International Cancer Center.

Read more Jiahui Health →

$Prof. Sun Yuan's Team Reports Low-Dose Long-Course VP16 Induction Bridge Therapy for Refractory/Relapsed HLH$

Beijing Jingdu Children's Hospital Research Aug 14, 2026

Prof. Sun Yuan's Team Reports Low-Dose Long-Course VP16 Induction Bridge Therapy for Refractory/Relapsed HLH

Dr. Jiang Fan from Beijing Jingdu Children's Hospital presents research on low-dose long-course etoposide (VP16) induction therapy for refractory/relapsed hemophagocytic lymphohistiocytosis (HLH) at the 2026 Pediatric Hematology-Oncology Symposium in Shenzhen.

BDG Brain Hospital Health Education Aug 14, 2026

Now Open: 10th Donglei Neurointerventional Training Class — September 12-13, 2026

Registration open for the 10th Donglei Brain Neurointerventional Training Class, September 12-13, 2026 in Shanghai. Lecture + live surgery + case discussion + Mentice simulator. Faculty: Prof. Song Donglei, Dr. Wang Wei, Dr. Gai Yanting, Dr. Pu Benfang, Dr. Tan Shubin, Dr. Yin Cheng. Free registration; 1.5 Shanghai CME credits.

Read more BDG Brain Hospital →

Arion Cancer Hospital Health Education Aug 14, 2026

Tarlatamab and DLL3/CD3 Bispecific Immunotherapy for Small Cell Lung Cancer

A plain-language science overview of small cell lung cancer (SCLC) and DLL3/CD3 bispecific T-cell engager immunotherapy, using tarlatamab as an example: how the dual-targeting mechanism works, which patient groups were studied in trials, and what the safety data show. Educational content, not medical advice.

Read more Arion Cancer Hospital →

GOBROAD Medical Group Hospital News Aug 14, 2026

Trastuzumab Rezetecan Approved for HER2+ Colorectal Cancer

NMPA approves SHR-A1811 (trastuzumab rezetecan) for HER2-positive CRC. Phase 3 HORIZON-CRC01: PFS 5.5 vs 2.8 mo (HR 0.33), ORR 40.7% vs 4.5%. Led by Prof. Li Jin at Shanghai GOBROAD Cancer Hospital.

Read more GOBROAD Medical Group →

Beijing Amcare Hospital Health Education Aug 13, 2026

ICL Lens Implantation at AMCARE Beijing: Your Guide to Pain, Halos, and Recovery

ICL is not laser surgery — it is a reversible, additive lens implant. Learn what to expect from the procedure, recovery, and night vision at AMCARE Beijing.

Read more Beijing Amcare Hospital →

Foshan Chancheng Hospital Medical Milestone Aug 11, 2026

First Iloprost Injection in Foshan: 80-Year-Old Diabetic Foot Patient Avoids Amputation

Foshan Chancheng Hospital gave the first local Iloprost injection under the Greater Bay Area policy, opening a new limb-salvage pathway for severe diabetic foot.

Read more Foshan Chancheng Hospital →

Foshan Chancheng Hospital Patient Story Aug 11, 2026

Across the Ocean for TCM: Overseas Patient Finds Hope for Chronic Kidney Disease

An overseas patient who had sought care in Singapore came to Foshan Chancheng Hospital for a 10-day integrated TCM program; renal markers and symptoms improved.

Read more Foshan Chancheng Hospital →

Foshan Chancheng Hospital Patient Story Aug 07, 2026

Da Vinci Precision Beyond Borders: Vietnamese Patient’s Robotic Lung Surgery

A da Vinci robotic right lower lobectomy removes a suspicious lung nodule while preserving healthy tissue and minimizing trauma, supported by FIMC international services.

Read more Foshan Chancheng Hospital →

Jiahui Health Men's Health Aug 06, 2026

Summer Men's Health: Itch, Odor, Pain — When Washing Isn't Enough

A Jiahui urologist explains why summer worsens male genital irritation, when self-treatment is risky, and how circumcision decisions are made.

Read more Jiahui Health →

Beijing Edencare Hospital Neurology Aug 06, 2026

Relief from Stubborn Post-Shingles Nerve Pain: How Ultrasound-Guided Pulsed Radiofrequency Helped a Patient Sleep Again — Beijing Edencare Hospital

Beijing Edencare Hospital's pain-management team explains postherpetic neuralgia and how ultrasound-guided pulsed radiofrequency can help calm overactive nerve signals after shingles.

Read more Beijing Edencare Hospital →

Arion Cancer Hospital Case Study Aug 06, 2026

Case Study: Occult Hematuria and Advanced Bladder Cancer in an Elderly Patient

A case-based educational overview: how multidisciplinary team (MDT) evaluation helped diagnose advanced metastatic bladder cancer in an 82-year-old patient initially misdiagnosed, and how low-toxicity ADC plus immunotherapy was chosen over standard chemotherapy. Educational content, not medical advice.

Read more Arion Cancer Hospital →

HYGEIA Healthcare Case Breakthrough Aug 06, 2026

"Starving" the Tumor — TACE Saves 17-Year-Old with Sacral Nerve Malignancy

Chongqing HYGEIA Hospital treated a 17-year-old girl with sacral nerve malignant tumor using transcatheter arterial chemoembolization (TACE) through a brachial artery approach, cutting off the tumor's blood supply while sparing nerve function.

Read more HYGEIA Healthcare →

Beijing Amcare Hospital Health Education Aug 04, 2026

Quit-Smoking Clinic at AMCARE Beijing: Science-Based Help for Tobacco Dependence

Tobacco dependence is a brain-based medical condition, not a character flaw. AMCARE Beijing's quit-smoking clinic offers science-based tools to help you quit for good.

Read more Beijing Amcare Hospital →

Beijing Amcare Hospital Health Education Aug 04, 2026

Quitting Smoking: It's Not a Willpower Problem — AMCARE Beijing

Tobacco dependence changes the brain. AMCARE Beijing explains why willpower alone often fails, and how medical support can help you quit for good.

Read more Beijing Amcare Hospital →

GOBROAD Medical Group Case Study Aug 04, 2026

11-Year PCNSL Survivor: Transplant + CAR-T Brings New Life

Mr. Jiang's 11-year battle with primary CNS lymphoma: relapse after 8 years, high-risk autologous transplant with residual disease, and CAR-T consolidation at GOBROAD Hospital — a story of resilience and renewed hope.

Read more GOBROAD Medical Group →

GOBROAD Medical Group Research Aug 02, 2026

48-Month Peritoneal Control: CLDN18.2 CAR-T for Gastric Cancer

PCI 9 to 0 in 8 months, successful conversion surgery, and 48-month disease control — CLDN18.2-targeted CAR T-cell therapy transforms outcomes in advanced gastric cancer with peritoneal metastasis.

Read more GOBROAD Medical Group →

Guangzhou Concord Cancer Center Hospital News Jul 31, 2026

GCCC Physics Team Presents Research at 2026 Joint AAPM|COMP Annual Meeting; Prof. Yuanshui Zheng Attends and Exchanges Ideas

Guangzhou Concord Cancer Center's radiotherapy physics team presented 3 research papers at the 2026 Joint AAPM|COMP Meeting in Vancouver. Prof. Yuanshui Zheng attended as the sole Chinese hospital representative on the Particle Therapy Subcommittee.

Read more Guangzhou Concord Cancer Center →

Guangzhou Concord Cancer Center Hospital News Jul 31, 2026

GCCC Proton Therapy Serves Over 1,000 Patients: A Milestone in Precision Radiotherapy

Guangzhou Concord Cancer Center's Proton Therapy Center has served over 1,000 patients in just 19 months of operation, achieving world-class efficiency with over 100 treatment sessions per day. Learn about the comprehensive proton therapy workflow, patient outcomes, and international comparisons.

Read more Guangzhou Concord Cancer Center →

Beijing Jingdu Children's Hospital Research Jul 31, 2026

Understanding Cleft Lip and Palate Sequential Treatment: A Multidisciplinary Relay from Infancy to Adulthood

A deep dive into cleft lip and palate sequential treatment at Beijing Jingdu Children's Hospital. Learn how oral and maxillofacial surgery, orthodontics, speech pathology, ENT, and psychology teams collaborate across 8 stages — from newborn feeding guidance through adult corrective surgery — to deliver comprehensive, long-term care.

Arion Cancer Hospital Health Education Jul 31, 2026

Understanding Precision Radiotherapy for Primary Brain Tumors

A plain-language overview of how precision radiotherapy works for primary brain tumors — what it is, who may be considered a candidate, and how it fits into the broader treatment framework. Educational content, not medical advice.

Read more Arion Cancer Hospital →

Foshan Chancheng Hospital Patient Story Jul 31, 2026

20-Year-Old Bangladeshi Patient's Da Vinci Kidney-Sparing Surgery

A 20-year-old woman with TSC-related kidney tumor traveled 2,800 km from Dhaka to Foshan for robot-assisted surgery that preserved her kidney.

Read more Foshan Chancheng Hospital →

GOBROAD Medical Group Clinical Trial Jul 29, 2026

HORIZON-CRC01 at ASCO 2026: Trastuzumab Rezetecan Reshapes HER2+ mCRC

World's first Phase 3 trial: trastuzumab rezetecan achieved median PFS 5.5 mo vs 2.8 mo SOC (HR 0.33) in HER2-positive mCRC. Presented by Prof. Li Jin at ASCO 2026.

Read more GOBROAD Medical Group →

GOBROAD Medical Group Clinical Trial Jul 29, 2026

JS107 Phase 3 Trial: CLDN18.2+ Gastric/GEJ Cancer Recruitment

Phase 3 multicenter RCT: JS107 anti-CLDN18.2 ADC vs investigator's choice for CLDN18.2-positive advanced gastric or GEJ adenocarcinoma. Recruiting at Shanghai GOBROAD Cancer Hospital.

Read more GOBROAD Medical Group →

GOBROAD Medical Group Hospital News Jul 29, 2026

Prof. Li Jin at ASCO 2026: Chinese Original ADCs Reshape GI Cancer Treatment

Exclusive interview: Prof. Li Jin on HORIZON-CRC01 Phase 3 success, CLDN18.2 ADC LM-302 first-line data, and how Chinese original research is leading global GI oncology innovation at ASCO 2026.

Read more GOBROAD Medical Group →

HYGEIA Healthcare Case Breakthrough Jul 29, 2026

From Death's Door to Safety — MDT Rescues 36-Year-Old from Post-Surgical Pulmonary Embolism

Chongqing HYGEIA Hospital's multidisciplinary team saved a 36-year-old breast cancer patient from acute massive pulmonary embolism using mechanical aspiration thrombectomy, local targeted thrombolysis, and IVC filter placement — all within a single minimally invasive procedure.

Read more HYGEIA Healthcare →

GOBROAD Medical Group Clinical Trial Jul 27, 2026

IPG7236 + Toripalimab Advanced Solid Tumor Trial — Recruitment

Phase I/II trial at Shanghai GOBROAD Cancer Hospital: IPG7236 (novel CCR8 antagonist) combined with toripalimab for advanced or recurrent solid tumors. Led by Dr. Zhou Jun.

Read more GOBROAD Medical Group →

Beijing Edencare Hospital International Patient Care Jul 26, 2026

Borderless Care in One Day: How a Foreign Patient Navigated Complex Chronic Care at Beijing Edencare Hospital — MedTourChina

A foreign patient from the Solomon Islands received one-day multidisciplinary care at Beijing Edencare Hospital, covering cardiology, endocrinology, ENT, gastroenterology, and functional medicine with English-language coordination.

Read more Beijing Edencare Hospital →

Arion Cancer Hospital Health Education Jul 25, 2026

Understanding Breast Nodules, Nipple Discharge, and Breast Cancer Screening

A patient education overview of common breast concerns: what breast nodules mean, when nipple discharge warrants evaluation, how breast cancer screening works, and an introduction to minimally invasive diagnostic techniques. Educational content, not medical advice.

Read more Arion Cancer Hospital →

Foshan Chancheng Hospital International Exchange Jul 25, 2026

Across Mountains and Seas, Medicine Connects

A delegation of 14 senior healthcare professionals from seven South Pacific island nations visited FIMC for clinical exchange and TCM experience.

Read more Foshan Chancheng Hospital →

Beijing Jingdu Children's Hospital Patient Story Jul 24, 2026

Trust Across Mountains and Seas: An International Family's Cleft Lip Journey at Jingdu

A foreign family traveled to Beijing Jingdu Children's Hospital for their baby's unilateral third-degree cleft lip. After thoughtful multidisciplinary care, the child recovered well — and the family sent a heartfelt bilingual thank-you letter.

Beijing Jingdu Children's Hospital Research Jul 24, 2026

A Landmark Event Ahead: Neuroblastoma Treatment Progress and Academic Heritage Exchange Conference

Beijing Jingdu Children's Hospital co-hosts the Neuroblastoma Treatment Progress and Academic Heritage Exchange Conference on August 8, 2026, chaired by Prof. Zhang Jinhua and Prof. Sun Yuan.

GOBROAD Medical Group Case Study Jul 24, 2026

Nearly 9 Years in Complete Remission After CAR-T for B-ALL: He Has Helped Thousands

A Feng survived B-ALL through CD19 CAR-T therapy at Beijing GOBROAD Boren Hospital and has spent nearly 9 years volunteering as a tuina massage therapist, helping thousands of patients and caregivers.

Read more GOBROAD Medical Group →

GOBROAD Medical Group Clinical Trial Jul 24, 2026

Clinical Trial Recruitment: IPG7236 Plus Toripalimab for Advanced Solid Tumors

Shanghai GOBROAD Cancer Hospital enrolls patients in a Phase I/II study of IPG7236 (novel CCR8 antagonist) plus toripalimab for advanced or recurrent malignant solid tumors.

Read more GOBROAD Medical Group →

GOBROAD Medical Group Clinical Trial Jul 24, 2026

MM CAR-T Clinical Trial: New Hope for Lenalidomide-Resistant Patients

Beijing GOBROAD Boren Hospital is recruiting lenalidomide-resistant R/R MM patients for a Phase III trial of Equecabtagene Autoleucel (CT103A).

Read more GOBROAD Medical Group →

Beijing Jingdu Children's Hospital Research Jul 21, 2026

AYA Oncology Frontiers: International Exchange on Adolescent and Young Adult Cancer Care

On July 21, 2026, Professor Stuart Siegel, founder of the Division of Hematology-Oncology at Children's Hospital Los Angeles and Honorary Professor at Beijing Jingdu Children's Hospital, delivered an academic lecture on AYA oncology at Jingdu.

Beijing Edencare Hospital Orthopedics & Sports Medicine Jul 19, 2026

Reconstructing a Severely Injured Finger: How Microsurgery Restores Function and Appearance — Beijing Edencare Hospital

Beijing Edencare Hospital's Reconstructive & Microsurgery team explains how microsurgical finger reconstruction restores function and natural appearance after severe hand trauma, supported by a 24/7 trauma channel.

Read more Beijing Edencare Hospital →

Guangzhou Concord Cancer Center Hospital News Jul 17, 2026

Advanced Bilateral Breast Cancer with Multiple Metastases: How MDT Care Helped Her Regain Independence

A patient with advanced bilateral breast cancer and multiple metastases received multidisciplinary, stratified care at Guangzhou Concord Cancer Center, achieving tumor regression and restored quality of life.

Read more Guangzhou Concord Cancer Center →

Arion Cancer Hospital Case Breakthrough Jul 17, 2026

Elderly Laryngeal Cancer Patient Develops Acute Abdomen — MDT Diagnoses Internal Hernia

A nearly 70-year-old man with early-stage glottic laryngeal cancer (T1aN0M0) developed sudden acute abdominal pain just before starting concurrent radiotherapy and targeted therapy. Despite no prior abdominal surgery history, Arion's MDT team identified a rare internal hernia through serial CT monitoring and 3D reconstruction, performed emergency exploratory laparotomy, and successfully preserved his eligibility for subsequent laryngeal cancer treatment.

Read more Arion Cancer Hospital →

Jiahui Health Medical Breakthrough Jul 16, 2026

New Drug Arrives at Jiahui: World's First Approved Bispecific ADC Izalontamab Brengitecan Begins Clinical Use

The world's first EGFR×HER3 bispecific ADC is now available at Jiahui International Cancer Center, offering a new precision option for recurrent or metastatic nasopharyngeal carcinoma.

Read more Jiahui Health →

Guangzhou Concord Cancer Center Hospital News Jul 16, 2026

Crossing the Lancang-Mekong, Linked by Protons: Cambodian Oncology Delegation Visits Guangzhou Concord Cancer Center

A Cambodian oncology delegation led by Prof. Dr. Eav Sokha visited Guangzhou Concord Cancer Center to explore proton therapy, international patient services, and Sino-Cambodian cancer-care collaboration.

Read more Guangzhou Concord Cancer Center →

Shanghai Peace Eye Hospital Clinical Milestone Jul 14, 2026

National First-in-Country | Shanghai HePing Eye Hospital Completes First TECNIS Odyssey Full Vision Range IOL Implants

Shanghai HePing Eye Hospital, led by President Prof. Guo Haike, becomes one of the first centers in China to clinically implant the Johnson & Johnson TECNIS Odyssey full-vision-range intraocular lens.

Read more Shanghai Peace Eye Hospital →

Guangzhou Concord Cancer Center Hospital News Jul 10, 2026

What Do Global Patients Choose When They Choose the Greater Bay Area?

Guangzhou Concord Cancer Center hosted a roundtable on regional international healthcare development, highlighting safety, standardization, and full-journey support for overseas patients.

Read more Guangzhou Concord Cancer Center →

Guangzhou Concord Cancer Center Hospital News Jul 10, 2026

World's First EGFR×HER3 Bispecific ADC Iza-Bren Prescribed at GCCC on Launch Day

Guangzhou Concord Cancer Center prescribed izalontamab brengitecan (Iza-Bren, Yizekang), the world's first EGFR×HER3 bispecific antibody-drug conjugate, on the first day of its commercial launch in Guangdong Province.

Read more Guangzhou Concord Cancer Center →

Beijing Jingdu Children's Hospital Research Jul 10, 2026

Jingdu Multidisciplinary Team Shines at 2026 Beijing Pediatrics Academic Annual Conference

Jingdu's hematology, oncology, gastroenterology, allergy, NICU and laboratory teams presented multiple studies at the 2026 Beijing Pediatrics Academic Annual Conference.

Beijing Jingdu Children's Hospital Research Jul 10, 2026

Dr. Liang Tianwei Presents at WOC 2026 in Prague

Dr. Liang Tianwei of Beijing Jingdu Children's Hospital delivered an oral paper on congenital cataract secondary glaucoma at the 40th World Ophthalmology Congress in Prague.

GOBROAD Medical Group Case Study Jul 10, 2026

Lung Adenocarcinoma with Leptomeningeal Metastasis — Case Study

How Shanghai GOBROAD Cancer Hospital diagnosed and treated a patient with occult leptomeningeal metastasis from lung adenocarcinoma using advanced black-blood MRI and a dedicated LM-MDT team.

Read more GOBROAD Medical Group →

Jiahui Health New Doctor Jul 09, 2026

Dr. Gamaliel VENTO Franco Joins Jiahui Emergency & Family Medicine

Jiahui welcomes Dr. Gamaliel VENTO Franco, multilingual emergency and family medicine physician with international disaster relief, ECMO, and air/ground medical transport experience.

Read more Jiahui Health →

Jiahui Health Medical Breakthrough Jul 09, 2026

World's First Solid Tumor CAR-T: First Foreign Patient Apheresis Completed at Jiahui

Jiahui International Cancer Center completes the first T-cell apheresis for a foreign patient using CT041 (Satri-cel), the world's first approved solid tumor CAR-T therapy.

Read more Jiahui Health →